Relative Bioavailability Study With BMS-955176
NCT02095886
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
47
Enrollment
INDUSTRY
Sponsor class
Conditions
Infection, Human Immunodeficiency Virus
Interventions
DRUG:
BMS-955176
Sponsor
ViiV Healthcare
Collaborators
[object Object]